Thymoquinone (TQ) inhibits inflammation by antagonizing IL-4/− 5 in asthma mice.
TQ suppresses the neovascularization and remodeling in vivo and in vitro.
TQ inhibits VEGF through PI3K/AKT signaling pathway in vivo and in vitro.
TQ up-regulates Slit-2 likely through the binding of Slit-2 and Robo-4.